RecruitingNCT06270056
Evaluation of Telemedicine Medical Abortion Service in Ecuador
Evaluation of Telemedicine Services to Address Urgent Issues Related to Sexual and Reproductive Rights in Ecuador
Sponsor
Gynuity Health Projects
Enrollment
100 participants
Start Date
Jul 24, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This research seeks to demonstrate that a telemedicine model for the provision of legal abortion services in Ecuador is safe, feasible and acceptable to users requesting a medication abortion and who are less than 12 weeks pregnant.
Eligibility
Sex: FEMALEMin Age: 15 Years
Inclusion Criteria9
- Woman is seeking abortion care and wants to use telemedicine service for her medication abortion procedure.
- Woman has access to an internet connection or a device that allows remote consultation.
- Woman is 15 years of age or older.
- Woman can provide an address to which abortion medications will be mailed.
- Woman reports having no contraindications to a medical abortion.
- The study provider does not suspect ectopic pregnancy or a nonviable pregnancy.
- The gestational age allows sufficient time for the woman to take the misoprostol no later than 84 days of gestation.
- A feasible plan is made that the woman agrees to confirm complete abortion and to seek care to manage incomplete abortion complications.
- The woman understands the study procedures and is likely to comply with study instructions and has granted informed consent to participate in the study.
Exclusion Criteria2
- Medically ineligible for procedure.
- Provider determines that a medical abortion using the telemedicine approach is not appropriate for that person.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGMisoprostol
Self-administered misoprostol by clients obtaining medication abortion via telemedicine
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06270056
Related Trials
PREgnancy and FERtility Registry
NCT0289516523 locations
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
NCT070768491 location
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
NCT029890251 location
MitoQ to Improve Vascular Funciton in Preeclampsia
NCT072292611 location
Efficacy and Adverse Side Effects of Two Forms of Iron in Pregnancy
NCT060149832 locations